Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Mobile app to boost cardiovascular health and exercise motivation during pregnancy

Official title: The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy

Run by Old Dominion University · NCT07166822 · Data updated 2026-11-12

This trial will test whether using the BumptUp mobile exercise app for eight weeks helps healthy pregnant women in their second trimester increase motivation to exercise and improve cardiovascular measures.

More Cardiovascular (CV) Risk trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment50 (estimated)
SponsorOld Dominion University
Academic / other
Locations1 site (Norfolk, Virginia)
StatusRecruiting
StartedSeptember 15, 2025
Main results expectedAugust 1, 2027
Study endsAugust 1, 2028
Registry record updatedSeptember 10, 2025
Trial IDNCT07166822 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking, generally healthy pregnant women aged 18-45 with a single pregnancy at 20-24 weeks who are sedentary (under 90 minutes of exercise per week), own a smartphone, and are under routine prenatal care.

Probably not a fit

Women with diagnosed cardiovascular or metabolic disease, significant musculoskeletal injury, on medications that affect vascular function, with multiple gestation, or who are already regularly exercising are unlikely to gain benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Healthy, sedentary pregnant women at 20-24 weeks gestation who are 18-45 years old will be assigned to either receive access to the BumptUp exercise app for eight weeks or to a comparison group that does not use the app. Both groups will attend baseline and follow-up lab visits where researchers will measure motivation with questionnaires and objective cardiovascular outcomes including flow-mediated dilation (FMD), heart rate variability (HRV), and pulse wave velocity (PWV). The intervention is delivered via the participant's smartphone and targets increases in habitual physical activity and exercise motivation. Outcomes after the eight-week period will be compared between the app and non-app groups to see if the app produces measurable changes.

Why it matters

Potential benefit: If successful, the app could increase pregnant women's motivation to exercise and produce measurable improvements in vascular health during the second trimester.

How similar studies have gone: Prior mobile-app and prenatal exercise interventions have shown some success increasing activity and motivation, but objective improvements in FMD, HRV, and PWV during pregnancy remain largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 18-45 years.
* Pregnant women who are 20-24 weeks pregnant at enrollment
* Sedentary, as defined by completing less than 90 minutes of exercise each week.
* Generally healthy, uncomplicated pregnancies.
* Free of physical limitations that may interfere with alterations in daily physical activity levels.
* Single gestation.
* Have a smartphone
* Under the routine medical care of an obstetrician or certified nurse midwife during their current pregnancy.
* Women speaking English.

Exclusion Criteria:

* Physician diagnosed cardiovascular/ vascular complications (heart disease, high blood pressure, Raynaud's phenomenon etc.)
* Physician diagnosed metabolic diseases (diabetes, hypothyroidism)
* Musculoskeletal injuries (broken bones, back pain, ankle sprain, muscle pull, etc.)
* Medications that may impact blood vessel function such as hypertension medication (Angiotensin converting enzyme inhibitor, Angiotensin receptor blocker, Calcium channel blocker, beta blocker), lipid lowering agents (statins), Nitrates, steroids, etc.
* Complications associated with pregnancy that would be exacerbated by exercise such as lung disease, persistent spotting/bleeding or Placental Previa, premature labor, ruptured membranes, evidence of intrauterine growth restriction, pregnancy induced hypertension or pre-eclampsia, uncontrolled epileptic fits/seizures.
* Smoking within the previous 3 months.

Where it's running

  • Old Dominion University
    Norfolk, Virginia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.